000153669 001__ 153669
000153669 005__ 20250508112648.0
000153669 0247_ $$2doi$$a10.3390/healthcare13080917
000153669 0248_ $$2sideral$$a143824
000153669 037__ $$aART-2025-143824
000153669 041__ $$aeng
000153669 100__ $$aSancho, David
000153669 245__ $$aIntegrating Lean Six Sigma into Microbiology Laboratories: Insights from a Literature Review
000153669 260__ $$c2025
000153669 5060_ $$aAccess copy available to the general public$$fUnrestricted
000153669 5203_ $$aBackground/Objectives: Clinical laboratories are fundamental to healthcare systems, contributing to over 70% of clinical decisions while accounting for only 2–3% of hospital budgets. Among them, microbiology laboratories provide critical information that directly influences patient outcomes and satisfaction. This study presents a structured review of the current state of Lean Six Sigma (LSS) implementation in microbiology and comparable laboratory environments. The objective is to identify relevant contributions within the state of the art to highlight potential benefits applicable to microbiology laboratories and to detect persistent gaps and unresolved needs. Methods: A systematic literature review was performed across six databases (Web of Science, ScienceDirect, Scopus, ProQuest, PubMed, and Google Scholar) to identify studies published between 2012 and September 2024. After screening, 33 studies were selected for full-text analysis. Results: The selected literature was analyzed to assess the extent to which LSS methodologies have been applied in microbiology laboratories. Particular attention was given to the definition and use of key performance indicators (KPIs). While industry-adapted metrics such as cost reduction and turnaround time are commonly employed, clinical indicators, such as patient impact, satisfaction, and diagnostic accuracy, are underutilized. Additionally, the analysis revealed a frequent omission of the control phase in LSS projects, limiting long-term process monitoring. The review also identifies the most suitable LSS tools and evaluates how laboratories manage interruptions in routine workflows. Conclusions: Future research should prioritize the integration of clinical KPIs into LSS frameworks, establish robust control phases for sustained monitoring, and systematically address the impact of process interruptions on optimization efforts.
000153669 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000153669 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000153669 700__ $$0(orcid)0000-0001-7294-245X$$aRezusta, Antonio
000153669 700__ $$0(orcid)0000-0002-4917-8550$$aAcero, Raquel$$uUniversidad de Zaragoza
000153669 7102_ $$15002$$2515$$aUniversidad de Zaragoza$$bDpto. Ingeniería Diseño Fabri.$$cÁrea Ing. Procesos Fabricación
000153669 773__ $$g13, 8 (2025), 917 [26 pp.]$$pHealthcare (Basel)$$tHealthcare (Switzerland)$$x2227-9032
000153669 8564_ $$s2626829$$uhttps://zaguan.unizar.es/record/153669/files/texto_completo.pdf$$yVersión publicada
000153669 8564_ $$s2569482$$uhttps://zaguan.unizar.es/record/153669/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000153669 909CO $$ooai:zaguan.unizar.es:153669$$particulos$$pdriver
000153669 951__ $$a2025-05-08-09:46:23
000153669 980__ $$aARTICLE